ACP

Acuta Capital Partners Portfolio holdings

AUM $71.6M
1-Year Est. Return 169.78%
This Quarter Est. Return
1 Year Est. Return
+169.78%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$99.4M
AUM Growth
-$24.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
49
New
Increased
Reduced
Closed

Top Buys

1
+$2.49M
2
+$1.98M
3
+$1.46M
4
NAMS icon
NewAmsterdam Pharma
NAMS
+$1.28M
5
ZYME icon
Zymeworks
ZYME
+$984K

Top Sells

1
+$7.4M
2
+$3.94M
3
+$3.85M
4
CMPS
Compass Pathways
CMPS
+$2.43M
5
TSHA icon
Taysha Gene Therapies
TSHA
+$2.14M

Sector Composition

1 Healthcare 99.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$984K 0.99%
+67,240
27
$971K 0.98%
+235,750
28
$904K 0.91%
160,200
+14,100
29
$883K 0.89%
21,000
-4,100
30
$845K 0.85%
9,150
-10,350
31
$824K 0.83%
10,743
-51,357
32
$755K 0.76%
+740,000
33
$512K 0.52%
49,800
+34,292
34
$444K 0.45%
44,000
35
$412K 0.41%
+18,139
36
$398K 0.4%
+74,307
37
$327K 0.33%
25,000
-21,600
38
$291K 0.29%
16,400
-1,200
39
$20.9K 0.02%
90,832
40
– –
-29,800
41
– –
-386,500
42
– –
-18,500
43
– –
-46,200
44
– –
-154,900
45
– –
-197,000
46
– –
-120,500
47
– –
-364,000
48
– –
-19,000
49
– –
-54,000
1
2